DATAROMA
Home
Commentaries/Articles
Superinvestors
Activity
S&P500 Grid
Grand Portfolio
RealTime
Insider
02 May 2016
Ackman: VRX undervalued, phone ringing for potential...
( Portfolio )
Bill Ackman, Pershing Square Capital CEO and portfolio manager, weighs in on when to invest in Valeant Pharmaceuticals.
Home
Help notes
Contact
Terms of Service
Privacy